Press Releases

All Releases
View Summary Ironwood Pharmaceuticals Announces First Quarter 2010 Investor Update Call and Upcoming Presentation at Bank of America Merrill Lynch 2010 Health Care Conference
May 7, 2010
PDF 14.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Annual Report on Form 10-K
Mar 30, 2010
PDF 13.2 KB Add to Briefcase
View Summary Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals' Initial Public Offering
Feb 16, 2010
PDF 16.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
Nov 20, 2009
PDF 12.6 KB Add to Briefcase
View Summary Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
Nov 10, 2009
PDF 14.1 KB Add to Briefcase
View Summary Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials In Patients with Chronic Constipation
Nov 2, 2009
PDF 20.7 KB Add to Briefcase
View Summary Marsha Fanucci Joins Ironwood Board of Directors
Oct 27, 2009
PDF 12.4 KB Add to Briefcase
View Summary Ironwood Appoints Thomas McCourt as Chief Commercial Officer and Senior Vice President of Marketing and Sales
Sep 14, 2009
PDF 12.5 KB Add to Briefcase
View Summary David Ebersman Joins Ironwood Board of Directors
Sep 14, 2009
PDF 12.2 KB Add to Briefcase
View Summary Ironwood And Forest Present Additional Positive Phase 2b Study Results For Linaclotide In Patients With Irritable Bowel Syndrome With Constipation
May 31, 2009
PDF 20.7 KB Add to Briefcase
View Summary Ironwood And Forest To Present Additional Phase 2b Data For Novel Gastrointestinal Agent Linaclotide
May 12, 2009
PDF 17.7 KB Add to Briefcase
View Summary Ironwood Announces Linaclotide European Licensing Agreement With Almirall
May 4, 2009
PDF 15.9 KB Add to Briefcase
  Ironwood Presents Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
Oct 21, 2008
PDF 137.5 KB Add to Briefcase
  Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
Oct 7, 2008
PDF 147.7 KB Add to Briefcase
  Ironwood and Collaborators Present Preclinical Data Demonstrating that Cyclic GMP Alleviates Intestinal Pain
Oct 6, 2008
PDF 135.1 KB Add to Briefcase
  Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
Oct 1, 2008
PDF 135.6 KB Add to Briefcase
  Ironwood and Forest to Present Positive Data from Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
Sep 23, 2008
PDF 146.5 KB Add to Briefcase
  Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
May 20, 2008
PDF 180.6 KB Add to Briefcase
  Microbia Announces Name Change to Ironwood Pharmaceuticals
Apr 7, 2008
PDF 32.1 KB Add to Briefcase
  Microbia Appoints Halley Gilbert as Vice President, General Counsel
Mar 31, 2008
PDF 39.7 KB Add to Briefcase
Showing 221-240 of 241 Page: 1 ... 8 9 10 11 12 13  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.